|
Business Growth BioPartnering at
BioTrinity 2008 -
Oxford, April 15-16, 2008
If you're not yet registered to attend BioTrinity 2008 -
Oxford, the leading biopartnering meeting and showcase for the
Oxford & South-East super-cluster, you may be missing
vital licensing, partnering, collaborative and investment
opportunities.
Over 400 delegates from over 300
companies will be reaping the benefits of attending BioTrinity -
Oxford (Apr 15-16 2008) in six weeks' time, according to our
projections.
Register now to ensure that you complete registration before the early bird rate expires (March 10th 5.00 PM GMT)
Continuing last year's success,
BioTrinity 2008 has already secured registration from over 140
companies. This year’s agenda features an international panel
of financial specialists in the biotech arena.
The panel will focus on
"Financing Alternatives in a Challenging Economy: IPO,
M&A and Other Non-Dilutive Financing." A topic
particularly relevant given today’s volatile financial market.
Chairperson to the discussion is Karl Keegan, Managing Director,
Head of Research (UK) and Global Sector Head of Life Sciences
Research at Cannacord Capital. He will be joined by
Niv Caviar, EVP, Chief Business and Chief Financial Officer,
La Jolla Pharmaceutical Co, San Diego, California;
Michael Bison, a partner at Goodwin Procter,
Boston, Massachusetts; Mike Wort, Managing Director and Head of
Investor Relations, De Facto Communications,
London; and Patrick Baddley, Corporate Finance partner at
Manches LLP, Oxford.
We are also delighted to announce that Peter Nolan, SVP Commercial Development, Oxford BioMedica will deliver the plenary key deal address on the $688m TroVax cancer vaccine deal and the ProSavin programme.
Take a look at the other
Companies Presenting listed below
Benefits of attending
-
Access to biotech, finance, pharma and advisors
-
Large private partnering room as standard
-
1000 partnering meetings over two days
-
High quality gold-standard one-to-one partnering system
-
International key notes and panel discussions on alliances, finance, partnering and biomanufacturing
-
Access to new contacts for business development
-
Access to 200 licensing opportunities
-
Plenary on the $688m TroVax licencing deal
...........................................................................................
BioTrinity 2007 testimonials:
"...I would like to congratulate you on an excellent
meeting.."
Tim Haines, Partner, Abingworth
Management
"...Congratulations on such a good event. I had a
very productive day with lots of organized and impromptu meetings -
a very worthwhile event for me."
Dr Charles Potter, CEO,
Glide Pharma
Read more
testimonials...
...........................................................................................
Companies Presenting at BioTrinity 2008 include:
Ablynx (Belgium)
a2sp Limited
Amphora Research
Systems
APA Parafricta
AstraZeneca
Atlas Venture
Biocompatibles
BioProcess Technology Consultants, Inc. (USA)
BioVex
Bristol-Myers Squibb
Capsant
Neurotechnologies
Celleron Therapeutics
ChemoCentryx
Chroma Therapeutics
Eden BioDesign
Equinox Pharma
Epidyme
Evotec UK Limited
Genzyme
Glide Pharma
G-Nostics
Hybrid Systems
International Bioscience
Isis Innovation
Karus Therapeutics
Lab Support UK Ltd
Lein Applied Diagnostics
MediGene
Merck Sharp Dohme
Momentum Bioscience Ltd
MP Healthcare Venture
Management
Oxford BioMaterials
Oxford Capital
Partners
Oxford Expression Technologie
Oxford Genome
Sciences
Pharmidex
Phynova
Physiomics plc
Shire
Pharma
Sofinnova Partners
Solace Pharma
Summit plc
SynCo
BioPartners (Netherlands)
Syntaxin
Tessella Support Services
plc
Your registration must be received on or before
March 10th 5:00 p.m. GMT, to qualify for the early bird rate. More
conference details are available online at: www.biotrinity.com
...........................................................................................
BioTrinity 2008 - Oxford: Prepare to
Partner!
If you are on the partnering circuit this year consider
registering for our BioTuesday event on maximising
value from BioPartnering held in Oxford one month before BioTrinity
2008 on March 18th, to make sure you gain the most value from
biopartnering. Featuring a highly experienced pharma partnering
speaker from Eli Lilly and a partnering system insider from EBD
group.
When spending time at BioTrinty 2008 don't forget that Oxford is a beautiful and historic city: Visit Oxford.
............................................................................................
Contact details:
Aruna Dudhia – Events Manager OBN
Suite L, Park House
11 Milton Park, Abingdon
Oxfordshire OX14 4RA
Tel. +44 (0)
1865 594640
Fax. +44 (0) 1235 835843
aruna.dudhia@oxfordshirebioscience.net
Register online now at www.biotrinity.com
............................................................................................
BioTrinity sponsors
  
  
  
  
 
............................................................................................
BioTrinity partners
  
  
............................................................................................
BioTrinity is organised by OBN
|
)